Virtual Abstracts & Posters 

Submit your research to be featured at LL&M Congress 2025. Accepted abstracts will be published in a supplement to the American Journal of Hematology, with awards given for top clinical and translational posters.

Thank you for considering sharing your hematologic malignancies research outcomes with the healthcare community at the 2025 Lymphoma, Leukemia & Myeloma Congress. 

• Increase Your Research Engagement. Seize the opportunity to present your work to more than 1,000 attendees at one of the most respected forums for industry-leading hematologic research and clinical case studies.
• Get Published. Accepted abstracts will be published in the American Journal of Hematology and shared on the Oncology Learning Network.
• Receive Accolades. Each year the Congress Chairs recognize the “Best of” submitted abstracts. Winning abstracts receive free congress registration.

Accepted abstracts will be published in the American Journal of Hematology and shared with attendees as digital posters accessible online. Only abstracts received by the submission deadline will be published.

**Abstract Submission Deadline EXTENDED: July 31, 2025, 11:59 PM ET 

Click here to access portal.

* Please note that we have modified the abstract submission guidelines. Industry authors can be the lead and/or senior author and can present the research onsite.

Abstract Categories

Abstracts will be accepted in the following categories:  ACUTE LEUKEMIA & MYELOPROLIFERATIVE / MYELODYSPLASTIC DISEASES, or MULTIPLE MYELOMA, or CHRONIC LYMPHOCYTIC LEUKEMIA, and/or LYMPHOMA. Please indicate which category is appropriate by checking the appropriate box in the online submission system. 

ACUTE LEUKEMIA & MYELOPROLIFERATIVE /  MYELODYSPLASTIC DISEASES CATEGORIES  

• A1. Clinical Trials, completed 
• A2. Procedures and Diagnostics 
• A3. Epidemiology and Outcomes Research 
• A4. Clinical Case Reports 
• A5. Trials in Progress in Leukemia

MULTIPLE MYELOMA CATEGORIES 

• M1. Clinical Trials, completed 
• M2. Procedures and Diagnostics 
• M3. Epidemiology and Outcomes Research 
• M4. Clinical Case Reports 
• M5. Trials in Progress in Multiple Myeloma

CHRONIC LYMPHOCYTIC LEUKEMIA CATEGORIES 

• C1. Clinical Trials, completed 
• C2. Procedures and Diagnostics 
• C3. Epidemiology and Outcomes Research 
• C4. Clinical Case Reports 
• C5. Trials in Progress in Chronic Lymphocytic Leukemia

LYMPHOMA CATEGORIES 

• L1. Clinical Trials, completed 
• L2. Procedures and Diagnostics 
• L3. Epidemiology and Outcomes Research 
• L4. Clinical Case Reports 
• L5. Trials in Progress in Lymphoma

Important Abstract Dates

Abstract Submission Deadline: July 31, 2025, 11:59 PM ET 

Abstract Notifications Mailed/Notified: on or before September 12, 2025 

Abstract Withdrawal Deadline: September 24, 2025 

Abstract Presenter Registration Deadline: October 3, 2025 

Upload Poster PDF Deadline: October 3, 2025 

Virtual Poster Display Dates: October 14–17, 2025 

LL&M Congress does NOT retain the copyright to the abstracts and posters presented at past or future conferences.  

We look forward to receiving your exciting work! Please reach out to us at hseymour@hmpglobal.com if you have questions about abstract submission.